Should Value Investors Buy Merck KGaA (MKKGY) Stock?
Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors use a variety of methods, including tried-and-true valuation metrics, to find these stocks.
On top of the Zacks Rank, investors can also look at our innovative Style Scores system to find stocks with specific traits. For example, value investors will want to focus on the "Value" category. Stocks with high Zacks Ranks and "A" grades for Value will be some of the highest-quality value stocks on the market today.
One company to watch right now is Merck KGaA (MKKGY). MKKGY is currently sporting a Zacks Rank #1 (Strong Buy), as well as an A grade for Value.
Investors will also notice that MKKGY has a PEG ratio of 1.85. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. MKKGY's PEG compares to its industry's average PEG of 1.99. Over the past 52 weeks, MKKGY's PEG has been as high as 2.31 and as low as 1.40, with a median of 2.01.
Finally, investors will want to recognize that MKKGY has a P/CF ratio of 6.30. This data point considers a firm's operating cash flow and is frequently used to find companies that are undervalued when considering their solid cash outlook. This company's current P/CF looks solid when compared to its industry's average P/CF of 12.68. MKKGY's P/CF has been as high as 17.18 and as low as 5.95, with a median of 7.25, all within the past year.
USANA Health Sciences (USNA) may be another strong Medical - Drugs stock to add to your shortlist. USNA is a Zacks Rank of #2 (Buy) stock with a Value grade of A.
USANA Health Sciences is trading at a forward earnings multiple of 10.36 at the moment, with a PEG ratio of 0.86. This compares to its industry's average P/E of 42.68 and average PEG ratio of 1.99.
Over the last 12 months, USNA's P/E has been as high as 17.00, as low as 7.83, with a median of 11.26, and its PEG ratio has been as high as 1.42, as low as 0.65, with a median of 0.94.
Additionally, USANA Health Sciences has a P/B ratio of 1.11 while its industry's price-to-book ratio sits at 1.63. For USNA, this valuation metric has been as high as 1.72, as low as 0.83, with a median of 1.22 over the past year.
These are only a few of the key metrics included in Merck KGaA and USANA Health Sciences strong Value grade, but they help show that the stocks are likely undervalued right now. When factoring in the strength of its earnings outlook, MKKGY and USNA look like an impressive value stock at the moment.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Merck KGaA (MKKGY) : Free Stock Analysis Report
USANA Health Sciences, Inc. (USNA) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
Gray Media (GTN) Stock Declines While Market Improves: Some Information for Investors
In the latest close session, Gray Media (GTN) was down 3.31% at $4.97. This move lagged the S&P 500's daily gain of 0.4%. Meanwhile, the Dow experienced a rise of 0.47%, and the technology-dominated Nasdaq saw an increase of 0.24%. Shares of the broadcast television company witnessed a gain of 12.97% over the previous month, beating the performance of the Consumer Discretionary sector with its gain of 2.16%, and the S&P 500's gain of 4.61%. The investment community will be closely monitoring the performance of Gray Media in its forthcoming earnings report. The company is scheduled to release its earnings on August 8, 2025. The company is predicted to post an EPS of -$0.34, indicating a 477.78% decline compared to the equivalent quarter last year. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of -$0.72 per share and revenue of $3.15 billion, indicating changes of -121.43% and -13.67%, respectively, compared to the previous year. Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Gray Media. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability. Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To take advantage of this, we've established the Zacks Rank, an exclusive model that considers these estimated changes and delivers an operational rating system. The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Gray Media currently has a Zacks Rank of #3 (Hold). The Broadcast Radio and Television industry is part of the Consumer Discretionary sector. Currently, this industry holds a Zacks Industry Rank of 153, positioning it in the bottom 39% of all 250+ industries. The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. You can find more information on all of these metrics, and much more, on Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Gray Media Inc. (GTN) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
a day ago
- Yahoo
Archer Aviation Inc. (ACHR) Outpaces Stock Market Gains: What You Should Know
Archer Aviation Inc. (ACHR) closed at $11.21 in the latest trading session, marking a +2% move from the prior day. The stock outpaced the S&P 500's daily gain of 0.4%. Meanwhile, the Dow experienced a rise of 0.47%, and the technology-dominated Nasdaq saw an increase of 0.24%. Shares of the company have appreciated by 3.78% over the course of the past month, underperforming the Aerospace sector's gain of 5.88%, and the S&P 500's gain of 4.61%. Investors will be eagerly watching for the performance of Archer Aviation Inc. in its upcoming earnings disclosure. The company is predicted to post an EPS of -$0.2, indicating a 16.67% growth compared to the equivalent quarter last year. In terms of the entire fiscal year, the Zacks Consensus Estimates predict earnings of -$0.76 per share and a revenue of $11.29 million, indicating changes of +32.74% and 0%, respectively, from the former year. Investors might also notice recent changes to analyst estimates for Archer Aviation Inc. Such recent modifications usually signify the changing landscape of near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability. Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To capitalize on this, we've crafted the Zacks Rank, a unique model that incorporates these estimate changes and offers a practical rating system. The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has remained unchanged. Archer Aviation Inc. is currently a Zacks Rank #3 (Hold). The Aerospace - Defense industry is part of the Aerospace sector. This group has a Zacks Industry Rank of 85, putting it in the top 35% of all 250+ industries. The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Make sure to utilize to follow all of these stock-moving metrics, and more, in the coming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Archer Aviation Inc. (ACHR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
a day ago
- Yahoo
Sensus Healthcare, Inc. (SRTS) Stock Drops Despite Market Gains: Important Facts to Note
Sensus Healthcare, Inc. (SRTS) closed at $5.51 in the latest trading session, marking a -2.48% move from the prior day. This move lagged the S&P 500's daily gain of 0.4%. At the same time, the Dow added 0.47%, and the tech-heavy Nasdaq gained 0.24%. Coming into today, shares of the company had gained 17.22% in the past month. In that same time, the Medical sector gained 1.19%, while the S&P 500 gained 4.61%. The upcoming earnings release of Sensus Healthcare, Inc. will be of great interest to investors. The company is predicted to post an EPS of $0.01, indicating a 90% decline compared to the equivalent quarter last year. Alongside, our most recent consensus estimate is anticipating revenue of $8.8 million, indicating a 4.76% downward movement from the same quarter last year. For the annual period, the Zacks Consensus Estimates anticipate earnings of $0.11 per share and a revenue of $41.95 million, signifying shifts of -73.17% and +0.34%, respectively, from the last year. Investors should also pay attention to any latest changes in analyst estimates for Sensus Healthcare, Inc. Recent revisions tend to reflect the latest near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential. Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Sensus Healthcare, Inc. presently features a Zacks Rank of #4 (Sell). Looking at valuation, Sensus Healthcare, Inc. is presently trading at a Forward P/E ratio of 51.36. For comparison, its industry has an average Forward P/E of 23.12, which means Sensus Healthcare, Inc. is trading at a premium to the group. The Medical - Instruments industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 165, finds itself in the bottom 34% echelons of all 250+ industries. The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Remember to apply to follow these and more stock-moving metrics during the upcoming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Sensus Healthcare, Inc. (SRTS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
